The price of Lantus insulin vials can vary depending on several factors, including the pharmacy, insurance coverage, and whether a discount card is used. As of late 2023, a Lantus SoloStar insulin pen starter kit (containing one pen and two cartridges) could range from approximately $300 to over $400 without insurance [1]. A single vial of Lantus insulin might be priced similarly or slightly lower.
How much does Lantus cost with insurance?
Insurance coverage significantly impacts the out-of-pocket cost of Lantus insulin. Many insurance plans offer preferred pricing for Lantus, potentially reducing the cost to a copay amount that could range from $0 to $50 or more per prescription, depending on the specific plan and formulary [2]. For individuals with high-deductible plans, the cost before meeting the deductible might be higher.
Are there ways to save money on Lantus?
Several options exist for reducing the cost of Lantus insulin. Sanofi, the manufacturer of Lantus, offers a Lantus Savings Card that can lower the cost for eligible commercially insured patients. This card could reduce the monthly cost to as little as $25, up to a maximum benefit [3]. For uninsured or underinsured patients, Sanofi also offers a Patient Assistance Program that may provide Lantus at no cost or a reduced cost based on income eligibility [4]. Additionally, some pharmacies may offer their own discount programs.
What is the difference between Lantus and other insulins like Basaglar or Toujeo?
Lantus is a long-acting insulin analog (insulin glargine) that provides a steady level of insulin for about 24 hours. Basaglar is a biosimilar to Lantus, meaning it is highly similar in terms of safety, efficacy, and quality, and is generally approved for the same uses [5]. Toujeo is another brand of insulin glargine, but it is a concentrated formulation (300 units/mL) compared to Lantus (100 units/mL), which may allow for a smaller injection volume and potentially longer duration of action for some individuals [6]. Prices can differ between these products, with biosimilars like Basaglar sometimes being more affordable.
When does Lantus patent exclusivity expire?
The original patent for Lantus expired in many regions several years ago, allowing for the development and introduction of biosimilar versions. For example, in the United States, key patents began to expire around 2015 [7]. The expiration of patents opens the door for generic or biosimilar competition, which can lead to price reductions.
Who makes Lantus insulin?
Lantus is manufactured by Sanofi, a global pharmaceutical company [8]. Sanofi also produces other insulin products, including Toujeo.